Clinical Report: What Reviews May Miss About Prolonged Grief Disorder

Overview

Revise to specify the critiques made by the JAMA Psychiatry Viewpoint regarding the AHRQ review.

Background

Prolonged grief disorder (PGD) is now recognized in major diagnostic manuals, highlighting the need for effective treatment options. Understanding the nuances of PGD and its specific therapeutic interventions is crucial for improving clinical outcomes. The recent AHRQ review's findings may mislead clinicians regarding the effectiveness of targeted therapies for PGD.

Data Highlights

No numerical data provided in the article.

Key Findings

Clinical Implications

Clinicians should prioritize PGD-specific therapies over general psychotherapies to enhance treatment efficacy. Awareness of the validated diagnostic tools and treatment frameworks for PGD can improve patient care and outcomes.

Conclusion

The interpretation of evidence regarding PGD is critical for its clinical management. Ensuring that targeted therapies are recognized and utilized can lead to better support for individuals experiencing prolonged grief.

References

1. JAMA Psychiatry, 2026 -- What Reviews May Miss About Prolonged Grief Disorder
2. DEPARTMENT OF HEALTH & HUMAN SERVICES, USA -- Interventions To Improve Care of Bereaved Persons
3. The ASCO Post, 2020 -- Cultivating Emotional Equanimity: Pause, Reflect, and Feel Meaning in Life, No Matter What
4. Intensive Care Medicine, 2009 -- Navigating Grief and Despair in Contrast to Resilience and Personal Development During Critical Illness
5. The ASCO Post, 2023 -- Being on the Other Side: An Oncologist’s Perspective on Grieving
6. Cognitive Function and Quality of Life in Long-Term High-Grade Glioma Survivors: Insights from Patients and Caregivers
7. Systematic ReviewInterventions To Improve Care of Bereaved PersonsDEPARTMENT OF HEALTH & HUMAN SERVICES, USA
8. Treatment of Complicated Grief in Elderly Persons: A Randomized Clinical Trial | Geriatrics | JAMA Psychiatry | JAMA Network